skip to main content
Mostrar Somente
Refinado por: assunto: Everolimus remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
Material Type:
Artigo
Adicionar ao Meu Espaço

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

Synold, Timothy W ; Plets, Melissa ; Tangen, Catherine M ; Heath, Elisabeth I ; Palapattu, Ganesh S ; Mack, Philip C ; Stein, Mark N ; Meng, Maxwell V ; Lara, Primo ; Vogelzang, Nicholas J ; Thompson, Ian Murchie ; Ryan, Christopher W

Kidney cancer, 2019-08, Vol.3 (2), p.111-118 [Periódico revisado por pares]

United States: IOS Press

Sem texto completo

2
Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)
Material Type:
Artigo
Adicionar ao Meu Espaço

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

Synold, Timothy W ; Plets, Melissa ; Tangen, Catherine M ; Heath, Elisabeth I ; Palapattu, Ganesh S ; Mack, Philip C ; Stein, Mark N ; Meng, Maxwell V ; Lara, Primo ; Vogelzang, Nicholas J ; Thompson, Ian Murchie ; Ryan, Christopher W

Kidney Cancer, 2019-01, p.1-8

eScholarship, University of California

Sem texto completo

Buscando em bases de dados remotas. Favor aguardar.